TAM (Treatments and Medicines) NHS Highland
Important: Therapy notes
Important: Formulation and dosage details
Formulation:
Solution for injection 120mg/mL (hospital use only)
Dosage:
As per SMC 2499: For the treatment of adult patients with visual impairment due to diabetic macular oedema (DMO).
SMC restriction: treatment of visual impairment due to DMO in adults with best corrected
visual acuity (BCVA) of 75 Early Treatment Diabetic Retinopathy Study (ETDRS) letters or less
at baseline.
and SMC 2512: for the treatment of adult patients with neovascular (wet) age-related macular degeneration (nAMD).